Patents by Inventor Adrian Waldner

Adrian Waldner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6576192
    Abstract: Fluoroionophores of formula (I) wherein R06 is H or substituted or unsubstituted C1-C20alkyl, R6 is H or substituted or unsubstituted C1-C30alkyl or C1-C30alkoxy, R1 is a bridging group, and F is a residue of a fluorophore. The fluoroionophores may be covalently bound to support materials and may be used as active components in polymer membranes of optical sensors for the detection of ions. The sensors are distinguished by short response times, a high degree of sensitivity and a long usable life.
    Type: Grant
    Filed: February 8, 1999
    Date of Patent: June 10, 2003
    Assignee: Novartis AG
    Inventors: Adrian Waldner, Steven Mark Barnard, Dirk Beckelmann, David Reinhoudt, Joseph Berger
  • Publication number: 20020183502
    Abstract: Therapeutic oligonucleotide analogs which have improved nuclease resistance and improved cellular uptake are provided. Replacement of phosphorodiester inter-sugar linkages found in wild type oligomers with four atom linking groups forms unique di- and poly-nucleosides and nucleotides useful in regulating RNA expression and in therapeutics. Methods of synthesis and use are also disclosed.
    Type: Application
    Filed: May 24, 2002
    Publication date: December 5, 2002
    Inventors: Alain De Mesmaeker, Jacques Lebreton, Adrian Waldner, Phillip Dan Cook
  • Patent number: 6417005
    Abstract: Fluoroionophores that are functionalised with reactive groups and correspond to the formula I—R1—F—R2—G, wherein I is a monovalen residue of an ionophore, wherein F is a divalent residue of a fluorophore, wherein G is a functional group and R1 and R2 are each independently of the other a direct bond or a bridging group. The fluoroionophores may be covalently bound to carrier materials and are used as active components in polymer membranes of optical sensors for the detection of ions. The sensors are distinguished by a long usable life and a high degree of sensitivity.
    Type: Grant
    Filed: December 7, 1998
    Date of Patent: July 9, 2002
    Assignee: Novartis AG
    Inventors: Steven Mark Barnard, Adrian Waldner, David Reinhoudt, Joseph Berger
  • Patent number: 6338822
    Abstract: A sensor for the optical determination by fluorescence of carbon dioxide in liquid and gaseous media, which consist essentially of a carrier and a light-sensitive layer applied thereto. In addition to a polymer as a base substance and an anionic fluorescence dye, the light-sensitive layer also contains a quaternary onium phenolate.
    Type: Grant
    Filed: February 18, 2000
    Date of Patent: January 15, 2002
    Assignee: Novartis AG
    Inventors: Adrian Waldner, Steven Mark Barnard
  • Patent number: 6303385
    Abstract: A water-insoluble copolymer which is composed of (a) from 39.9 to 60% by weight of N,N-dimethylacrylamide or N,N-dimethylmethacrylamide; (b) from 60 to 39.9% by weight of N-alkylated acryl amides or N-alkylated methacryl amides; (c) from 0.1 to 0.7% by weight of a proton-sensitive fluorophore which is covalently bonded to the copolymer; and (d) from 0 to 20% by weight of a diolefinic crosslinking component. The copolymer is used in the form of a membrane on a transparent support material as an optical sensor for ionic strength-independent pH value determination.
    Type: Grant
    Filed: March 8, 2001
    Date of Patent: October 16, 2001
    Assignee: Novartis AG
    Inventors: Steven Mark Barnard, Joseph Berger, Marizel Rouilly, Adrian Waldner
  • Patent number: 6294390
    Abstract: Compounds, constructed in modular manner, of formula (I), wherein I is the monovalent residue of an ionophore, F is the monovalent residue of a fluorophore, G is a functional group, T is a trivalent organic radical and R01, R02 and R03 are each independently of the others a direct bond or a bridging group. The compounds may be used in immobilized form as active components in polymer membranes of optical sensors for the detection of ions. The sensors are distinguished by a long usable life and a high degree of sensitivity.
    Type: Grant
    Filed: January 21, 1999
    Date of Patent: September 25, 2001
    Assignee: Novartis Ag
    Inventors: Steven Mark Barnard, René Beerli, Joseph Berger, David Reinhoudt, Adrian Waldner
  • Publication number: 20010018217
    Abstract: The invention relates to a polymer composition comprising pH-sensitive fluorescent dyes, to an ionic strength-independent optical sensor for pH value determination that contains the composition in the form of a membrane on a transparent support material, and to an optical process, according to the fluorescence method, that renders possible highly accurate pH value determination independently of the ionic strength of the test solution. The process is especially suitable for the determination of the pH value of physiological solutions, especially for the determination of the pH value of blood.
    Type: Application
    Filed: March 8, 2001
    Publication date: August 30, 2001
    Inventors: Steven Mark Barnard, Joseph Berger, Marizel Rouilly, Adrian Waldner
  • Patent number: 6252024
    Abstract: A water-insoluble copolymer which is composed of (a) from 39.9 to 60% by weight of N,N-dimethylacrylamide or N,N-dimethylmethacrylamide; (b) from 60 to 39.9% by weight of N-alkylated acryl amides or N-alkylated methacryl amides; (c) from 0.1 to 0.7% by weight of a proton-sensitive fluorophore which is covalently bonded to the copolymer; and (d) from 0 to 20% by weight of a diolefinic crosslinking component. The copolymer is used in the form of a membrane on a transparent support material as an optical sensor for ionic strength-independent pH value determination.
    Type: Grant
    Filed: November 2, 1998
    Date of Patent: June 26, 2001
    Assignee: Novartis AG
    Inventors: Steven Mark Barnard, Joseph Berger, Marizel Rouilly, Adrian Waldner
  • Patent number: 6245574
    Abstract: Sensors for the qualitative and quantitative determination of K+ ions in aqueous systems are described, which consist essentially of a carrier and an active layer applied to this carrier, whereby the active layer contains a polymer in which is dispersed at least one modified valinomycin, in which a radical of a fluorescence dye which emits in long waves, preferably an acridine or fluorescein, with an emission wave length of >550, is covalently bound.
    Type: Grant
    Filed: June 30, 1998
    Date of Patent: June 12, 2001
    Assignee: Novartis AG
    Inventors: Adrian Waldner, René Beerli, Steven Mark Barnard
  • Patent number: 6207461
    Abstract: Compounds of formula (I) wherein Me is Pd(II) or Pt(II); R is H or C1-C18 alkyl, or is C3-C8 cycloalkyl, phenyl, pyridyl or phenyl-C1-C4 alkylene, each of which is unsubstituted or substituted by C1-C18 alkyl, C1-C18 alkoxy, R3—O—C(O)—, halogen, —CN or by —NO2; R1 and R2 are each independently of the other H, C1-C12 alkyl or C1-C12 alkoxy or R1 and R2 together are —OCH2O—, —OCH2CH2O—, or —CH═CH—CH═CH—, and R3 is C1-C18 alkyl, C3-C18 cycloalkyl, phenyl, benzyl, C1-C12 alkylphenyl or C1-C12 alkylbenzyl. Compounds of formula (I) are valuable luminophores and/or intermediates for the preparation of palladium (II) or platinum (II) benzoporphyrins, which are likewise luminophores.
    Type: Grant
    Filed: January 21, 1999
    Date of Patent: March 27, 2001
    Assignee: Novartis AG
    Inventors: Marcus Baumann, Adrian Waldner
  • Patent number: 6165800
    Abstract: A new class of chemiluminescent acridinium or benzacridinium compounds is disclosed by virtue of forming an intramolecular energy transfer conjugate (ETC) between the acridinium or benzacridinium compound and a luminophore. A method of extending the emission wavelengths of acridinium or benzacridinium esters in order to further reduce or eliminate the emission spectral overlap between the parent polysubstituted aryl Acridinium Esters (DMAE) and Benzacridinium Esters (LEAE) is disclosed. The ETC's retain the unique desired properties of acridinium or benzacridinium compounds including complete light emission in very short period of time, monophasic emission spectrum, simplicity of triggering mechanism, ability of labeling the biological molecules of interest to form a tracer, and good stability. Additionally, the range of the emission spectrum of an acridinium or benzacridinium compound can now be shifted at will and at longer leap through the choice of a luminophore as the integral part of an ETC molecule.
    Type: Grant
    Filed: May 27, 1998
    Date of Patent: December 26, 2000
    Assignee: Bayer Corporation
    Inventors: Qingping Jiang, Jun Xi, Anand Natrajan, David Sharpe, Marcus Baumann, Rolf Hilfiker, Erika Schmidt, Paul Senn, Fritz Thommen, Adrian Waldner, Alex Alder, Say-Jong Law
  • Patent number: 6066447
    Abstract: Oligonucleotides of the formula: 5'(U).sub.n -3' in which U is an identical or different radical of a natural or a synthetic nucleoside and n is a number from 2 to 200 comprising at least one structural unit of two consecutive nucleosides wherein one of the nucleotides is substituted in the 2'-position or wherein the nucleotides are substituted differently in their 2'-position and wherein the backbone is modified.
    Type: Grant
    Filed: November 12, 1996
    Date of Patent: May 23, 2000
    Assignee: Novartis Corporation
    Inventors: Alain De Mesmaeker, Adrian Waldner, Jacques Lebreton, Marc-Olivier Bevierre, Catherine Lesueur
  • Patent number: 5602240
    Abstract: Oligonucleotide analogs are provided wherein phosphodiester inter-sugar linkages are replaced with four atom linking groups. Such linking groups include NR--C(O)--CH.sub.2 --CH.sub.2, NR--C(S)--CH.sub.2 --CH.sub.2, CH.sub.2 --NR--C(O)--CH.sub.2, CH.sub.2 --NR--C(S)--CH.sub.2, CH.sub.2 --CH.sub.2 --NR--C(O)--R--CH.sub.2, and CH.sub.2 --C(S)--NR--CH.sub.2. Methods for preparing and using these oligonucleotide analogs are also provided.
    Type: Grant
    Filed: April 25, 1994
    Date of Patent: February 11, 1997
    Assignees: Ciba Geigy AG., Isis Pharmaceuticals, Inc.
    Inventors: Alain De Mesmaeker, Jacques Lebreton, Adrian Waldner, Phillip D. Cook
  • Patent number: 4999426
    Abstract: Compounds of formula I ##STR1## in which R is H, or an aliphatic or aromatic radical, R.sup.1 is alkyl, R.sup.2 is alkyl, alkoxy, aryl, aryloxy, aralkyl, alkaryl, aralkyloxy, alkaryloxy, alkaralkyl or alkaralkyloxy, and one of R.sup.1 and R.sup.2 is H and the other has the meaning given above. These compounds are intermediates for the preparation of herbicidal sulfonylureas.
    Type: Grant
    Filed: July 26, 1989
    Date of Patent: March 12, 1991
    Assignee: Ciba-Geigy Corporation
    Inventors: Adrian Waldner, Willy Meyer
  • Patent number: 4923993
    Abstract: The process of the invention relates to the reaction of hydrazones of formula II ##STR1## with .alpha.-chloro- or .alpha.-bromoarylonitrile or .alpha.-chloro- or .alpha.-bromoacrylates of formula III ##STR2## to 1-amino-2-cyano-1,4-dihydropyridines or 1-amino-1,4-dihydropyridine-2-carboxylic acid esters of formula IV ##STR3## which are converted into pyridine derivatives of formula I ##STR4## by treatment with an acid, with removal of R.sub.4 R.sub.5 NH. Y is --CN or --COOR.sub.3 and R.sub.1 to R.sub.5 may be alkyl.
    Type: Grant
    Filed: September 2, 1988
    Date of Patent: May 8, 1990
    Assignee: Ciba-Geigy Corporation
    Inventor: Adrian Waldner
  • Patent number: 4889933
    Abstract: Compounds of formula I ##STR1## in which R is H, or an aliphatic or aromatic radical, R.sup.1 is alkyl, R.sup.2 is alkyl, alkoxy, aryl, aryloxy, aralkyl, alkaryl, aralkyloxy, alkaryloxy, alkaralkyl or alkaralkyloxy, and one of R.sup.1 and R.sup.2 is H and the other has the meaning given above. These compounds are intermediates for the preparation of herbicidal sulfonylureas.
    Type: Grant
    Filed: September 12, 1988
    Date of Patent: December 26, 1989
    Assignee: Ciba-Geigy Corporation
    Inventors: Adrian Waldner, Willy Meyer
  • Patent number: 4754033
    Abstract: A process for producing pyridine-2,3-dicarboxylic acid derivatives of the formula ##STR1## is described. The process is based on the cleavage of HNR.sub.10 R.sub.11 from 1-amino-1,2,3,4-tetrahydropyridine-2,3-dicarboxylic acid derivatives of the formula II ##STR2## to give 1,4-dihydropyridine-2,3-dicarboxylic acid derivatives of the formula III ##STR3## and subsequent oxidation of these compounds to obtain pyridine-2,3-dicarboxylic acid derivatives of the formula I. According to one variant of the process, the 1,4-dihydropyridine-2,3-dicarboxylic acid derivatives of the formula III are obtained directly, without isolation of the intermediately formed 1-amino-1,2,3,4-tetrahydropyridine-2,3-dicarboxylic acid derivatives of the formula II, by reaction of .alpha.,.beta.-unsaturated hydrazones of the formula IV ##STR4## with ethene-1,2-dicarboxylic acid derivatives of the formula V ##STR5## and subsequently oxidized to pyridine-2,3-dicarboxylic acid derivatives of the formula I. In the above formulae, R.sub.1, R.
    Type: Grant
    Filed: August 2, 1985
    Date of Patent: June 28, 1988
    Assignee: Ciba-Geigy Corporation
    Inventor: Adrian Waldner
  • Patent number: 4748244
    Abstract: The invention relates to a process for the preparation of pyridine-2,3-dicarboxylic acid derivatives of formula ##STR1## which process comprises reacting a hydrazone of formula II ##STR2## with a maleic acid derivative of formula III ##STR3## to give a 1-amino-1,4-dihydropyridine-2,3-dicarboxylic acid derivative of formula IV ##STR4## and subsequently removing R.sub.9 R.sub.10 NH. In the above formulae, R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.9, R.sub.10 and X are as defined in claim 1. The pyridine-2,3-dicarboxylic acid derivatives of formula I are intermediates for the preparation of herbicidal compounds.
    Type: Grant
    Filed: May 3, 1985
    Date of Patent: May 31, 1988
    Assignee: Ciba-Geigy Corporation
    Inventors: Adrian Waldner, Achim Roloff, Daniel Bellus